why did the fda ban bpc-157 panel votes to ease restrictions on peptide The FDA Could Ban These

For example, a review by Gwyer and colleagues (2019) concluded that while studies have reported findings across experimental models, the majority of the evidence comes from laboratory and animal research

With the therapy done immediately after wounding, we performed the Akt1, Braf, Egfr, Egr1, Grb2, Hdac7, Kras, Mapk1, Mapk3, Mapk14, Nos3, Pik3cd, Plcg1, Prkcg, Ptk2, Pxn, Src, Srf , and Vegfa genes expression analysis in the rats excision wounds, in the skin, and subcutaneous tissue, done at 2, 5, and 10 min following BPC 157 application (Figure 8)

Spectroscopic discrimination of bee pollen by composition, color, and botanical origin

Myth: Shaking the vial helps the powder dissolve faster and better

So through those deals, BPC-157 ended up inside a giant generics company that had little interest in pushing an unproven peptide through the rest of clinical testing, and it got shelved)